REPROGRAMMING EXPERIENCE OF BLOOD MONONUCLEAR CELLS INTO INDUCED PLURIPOTENT STEM CELLS (IPSCS) IN A PATIENT WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)
Introduction. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited arrhythmia linked to RYR2 mutations. CPVT is a major cause of sudden cardiac death in the young. Here we outline the experience of induced pluripotent stem cells (iPSCs) generation from a healthy donor and a patient with CPVT. By establishing iPSCs from affected individuals, this study can reveal mechanisms of disease pathophysiology and the potential of iPSC technology to develop cardiogenetic research and personalized medicine.
Aim. To investigate experimental methods used to generate and validate iPSCs derived from a healthy donor with wild-type RYR2 and a patient with RYR2 mutation.
Materials and methods. A 33-year-old female patient with CPVT was genetically screened using Sanger sequencing, revealing a de novo RYR2 mutation (c.13892A>T; p.D4631V). Peripheral blood mononuclear cells of a healthy donor and a patient were isolated by density gradient centrifugation and reprogrammed into iPSCs using the Sendai virus method. Cells were cultured under feeder-free conditions in Essential 8™ Flex medium. Pluripotency was confirmed via several methods, such as immunocytochemistry and G-banding karyotyping.
Results. The isolated cells showed optimal morphology, with cell colonies displaying smooth, well-defined edges and a rounded shape. The cells within the colonies were densely packed. Immunostaining confirmed the expression of the pluripotency marker TRA-1-60. Karyotype analysis revealed that all derived cell lines maintained stable chromosomal integrity.
Conclusions. iPSCs were successfully generated from a healthy donor to serve as a “control” for comparison with patient-derived iPSCs carrying a de novo heterozygous RYR2 mutation (c.13892A>T; p.D4631V). This iPSC-based model offers a valuable platform for investigating CPVT pathophysiology and testing potential therapeutic approaches.
Number of Views: 437
Category of articles:
Original article
Bibliography link
Satvaldina N.N., Tolymbekova A., Rakhimova S.E., Abilova Zh.M., Akilzhanova A.R. Reprogramming experience of blood mononuclear cells into induced pluripotent stem cells (iPSCs) in a patient with catecholaminergic polymorphic ventricular tachycardia (CPVT) // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (4), pp. 7-13. doi 10.34689/SH.2025.27.4.001Related publications:
GENETIC VARIANTS IN LIPID-ASSOCIATED GENES IN THE KAZAKHSTANI COHORT WITH ATHEROSCLEROSIS AND HYPERTRIGLYCERIDEMIA
CLONAL HEMATOPOIESIS WITH INDETERMINATE POTENTIAL IN TET2 AND DNMT3A AMONG KAZAKHSTANI INDIVIDUALS WITH ATHEROSCLEROTIC DISEASE
PRELIMINARY ANALYSIS AND ASSESSMENT OF THE HEALTH STATUS OF THE DESCENDANTS OF PERSONS EXPOSED TO RADIATION, LIVING IN THE BESKARAGAI DISTRICT OF THE ABAY REGION
PRELIMINARY ANALYSIS OF THE HEALTH STATUS AND RADIATION DOSES OF RESIDENTS OF THE ABAY DISTRICT OF THE ABAY REGION, WHO ARE DESCENDANTS OF PERSONS EXPOSED TO RADIATION DUE TO NUCLEAR WEAPONS TESTS
TRENDS AND DISPARITIES IN CANCER MORBIDITY IN KAZAKHSTAN: A REGIONAL AND AGE-BASED ANALYSIS FOR 2014-2024